Litigation Against Zantac Manufacturers on the Rise Due to Evidence It May Cause Cancer

Who Are the Defendants in the Zantac Litigation?

Typically, when it comes to dangerous drug cases, it is the manufacturer who is named in any legal action.

For the Zantac litigation, the two major defendants are also the two largest manufacturers of the drug.

The main defendants in the class action include Sanofi and Boehringer Ingelheim.

Of course, both companies deny that their drug is unsafe.

They are also the two manufacturers who refused to voluntarily recall the drug back in September of 2019 when it was suggested by the FDA.

Of course, these are not the only companies that produce Zantac.

There are three (3) large drug manufacturing companies that also make the drug.

This includes Apotex, Sandoz, and GlaxoSmithKline.

However, all of these companies performed a voluntary recall when it was first announced that the NDMA levels in Zantac were dangerously high.

Once they chose to recall the drug from pharmacy shelves, two online pharmacies followed suit.

These companies were Vailsure and Emery Pharma.

The current litigation against Zantac manufacturers has been filed mostly against Sanofi and Boehringer Ingelheim.

They did not remove their product from the market until the FDA ordered them to do so on April 1, 2020.

It was at this point that testing revealed that the drug is unsafe, even when it has not been stored at high temperatures.

Two Large Verdicts Against Sanofi and Boehringer Ingelheim

Even though Zantac has been on the market since the 1980s, it wasn’t until recently that the drug has come under attack.

The pills come in three doses: 75 mg, 150 mg and 300 mg.

The 300 mg tablet is a once per day dose.

The others are taken as needed or several times throughout the day.

The testing was done on the 150 mg tablets.

The FDA found that these tablets contained NDMA levels that were more than 3,000 times the safe daily dose.

The lawsuits against the manufacturers of Zantac allege that, not only is the drug dangerous, but that the defendants were aware of it.

They claim that Sanofi and Boehringer Ingelheim were aware that the chemicals in Zantac were dangerous and hid it.

They argue that the company intentionally hid this information so that they continue to profit from the sale of the drug.

In 2019, a suit against Sanofi and Boehringer Ingelheim resulted in the second largest verdict in the U.S. The case settled for more than $2 billion.

Another case resulted in a judgment of more than $289 million.

Today, not only are there thousands of lawsuits pending, there are now the first batch of cases being filed on behalf of children.

Contact an Experienced Arkansas Personal Injury Lawyer Right Away

If you or your child have been diagnosed with cancer after taking Zantac, you need help.

You should call and talk to one of our experienced personal injury attorneys in Arkansas sooner rather than later to discuss possible litigation against Zantac manufacturers.

You only have three (3) years to file suit in Arkansas.

Call and schedule your free initial consultation as soon as possible.

And remember – you don’t pay anything until your case settles.